The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met ...

The series A financing will enable Nura Bio to advance its lead drug candidate into the next stage of clinical trials, ...

Alison has more than 35 years of broad experience delivering clinical trials to sponsors with a patient centric mindset.

The German big pharma will submit a new drug application to the US FDA after success at phase 3 for nerandomilast.

Applying AI-enabled route scouting services allows drug developers to avoid pitfalls that can typically occur in drug ...

One year after a rejection by the US Food and Drug Administration (FDA), the UK firm F2G has raised $100 million to push its candidate olorofim to the market for the treatment of rare fungal ...

Rachel Sha has had a colorful career not without its challenges, but she urges women in the science industry to have ...

Motif, a fast-growing company in the clinical research technology sector, has taken a significant step in expanding its ...

Phastar have implemented an RBQM app within their Clinical Intelligence Data Visualisation Platform, enabling a comprehensive overview of the entire trial across all sites which can be shown in ...

The European Organisation for Research and Treatment of Cancer (EORTC) has renewed and extended its partnership with Medidata, a provider of clinical trial solutions for the life sciences industry.

Recent investments by major pharmaceutical companies signal a growing confidence in artificial intelligence’s (AI's) potential to transform drug development. In this Q&A, Dr Fabrice Chartier (FC), CEO ...